Yes, catalytic processes are pivotal in the development of diagnostic tools. Enzyme-linked immunosorbent assays (ELISAs), which are used to detect diseases like HIV and cancer, rely on catalytic reactions to amplify signals for better detection sensitivity. This enables early diagnosis and timely treatment, significantly improving patient outcomes.